Knockdown of TRIM11 inhibited glioma cell proliferation, migration, and invasion, whereas low levels of TRIM11 resulted in downregulation of EGFR, p-c-Raf, p-MEK1/2, and p-44/42MAPK. The gene discussed is EGFR; the disease is central nervous system cancer.